HEADER HYDROLASE/HYDROLASE INHIBITOR 25-FEB-04 1SHH
TITLE SLOW FORM OF THROMBIN BOUND WITH PPACK
CAVEAT 1SHH NAG E 701 HAS WRONG CHIRALITY AT ATOM C1
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: THROMBIN;
COMPND 3 CHAIN: A, D;
COMPND 4 FRAGMENT: THROMBIN LIGHT CHAIN (A);
COMPND 5 SYNONYM: COAGULATION FACTOR II;
COMPND 6 ENGINEERED: YES;
COMPND 7 MOL_ID: 2;
COMPND 8 MOLECULE: THROMBIN;
COMPND 9 CHAIN: B, E;
COMPND 10 FRAGMENT: THROMBIN HEAVY CHAIN (B);
COMPND 11 SYNONYM: COAGULATION FACTOR II;
COMPND 12 EC: 3.4.21.5;
COMPND 13 ENGINEERED: YES;
COMPND 14 MUTATION: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 3 ORGANISM_COMMON: HUMAN;
SOURCE 4 ORGANISM_TAXID: 9606;
SOURCE 5 GENE: F2;
SOURCE 6 EXPRESSION_SYSTEM: CRICETULUS GRISEUS;
SOURCE 7 EXPRESSION_SYSTEM_COMMON: CHINESE HAMSTER;
SOURCE 8 EXPRESSION_SYSTEM_TAXID: 10029;
SOURCE 9 MOL_ID: 2;
SOURCE 10 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 11 ORGANISM_COMMON: HUMAN;
SOURCE 12 ORGANISM_TAXID: 9606;
SOURCE 13 GENE: F2;
SOURCE 14 EXPRESSION_SYSTEM: CRICETULUS GRISEUS;
SOURCE 15 EXPRESSION_SYSTEM_COMMON: CHINESE HAMSTER;
SOURCE 16 EXPRESSION_SYSTEM_TAXID: 10029
KEYWDS SERINE PROTEASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
EXPDTA X-RAY DIFFRACTION
AUTHOR A.O.PINEDA,C.J.CARRELL,L.A.BUSH,S.PRASAD,S.CACCIA,Z.W.CHEN,
AUTHOR 2 F.S.MATHEWS,E.DI CERA
REVDAT 8 16-OCT-24 1SHH 1 REMARK
REVDAT 7 13-MAR-24 1SHH 1 COMPND SOURCE
REVDAT 6 27-OCT-21 1SHH 1 SEQADV HETSYN
REVDAT 5 29-JUL-20 1SHH 1 CAVEAT COMPND REMARK HETNAM
REVDAT 5 2 1 LINK SITE
REVDAT 4 13-JUL-11 1SHH 1 VERSN
REVDAT 3 24-FEB-09 1SHH 1 VERSN
REVDAT 2 27-JUL-04 1SHH 1 JRNL
REVDAT 1 08-JUN-04 1SHH 0
JRNL AUTH A.O.PINEDA,C.J.CARRELL,L.A.BUSH,S.PRASAD,S.CACCIA,Z.W.CHEN,
JRNL AUTH 2 F.S.MATHEWS,E.DI CERA
JRNL TITL MOLECULAR DISSECTION OF NA+ BINDING TO THROMBIN.
JRNL REF J.BIOL.CHEM. V. 279 31842 2004
JRNL REFN ISSN 0021-9258
JRNL PMID 15152000
JRNL DOI 10.1074/JBC.M401756200
REMARK 2
REMARK 2 RESOLUTION. 1.55 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : CNS 1.1
REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE-
REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU,
REMARK 3 : READ,RICE,SIMONSON,WARREN
REMARK 3
REMARK 3 REFINEMENT TARGET : ENGH & HUBER
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.55
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 81.47
REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000
REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL
REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL
REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 92.1
REMARK 3 NUMBER OF REFLECTIONS : 92091
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT
REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM
REMARK 3 R VALUE (WORKING SET) : 0.195
REMARK 3 FREE R VALUE : 0.216
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000
REMARK 3 FREE R VALUE TEST SET COUNT : 4598
REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.003
REMARK 3
REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN.
REMARK 3 TOTAL NUMBER OF BINS USED : NULL
REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.55
REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.62
REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 61.70
REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 7261
REMARK 3 BIN R VALUE (WORKING SET) : 0.3100
REMARK 3 BIN FREE R VALUE : 0.3090
REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.80
REMARK 3 BIN FREE R VALUE TEST SET COUNT : 363
REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.016
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 4588
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 75
REMARK 3 SOLVENT ATOMS : 483
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : 18.80
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 24.90
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : 6.73000
REMARK 3 B22 (A**2) : -1.37000
REMARK 3 B33 (A**2) : -5.36000
REMARK 3 B12 (A**2) : 0.00000
REMARK 3 B13 (A**2) : 0.00000
REMARK 3 B23 (A**2) : 0.00000
REMARK 3
REMARK 3 ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.18
REMARK 3 ESD FROM SIGMAA (A) : 0.25
REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00
REMARK 3
REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.21
REMARK 3 ESD FROM C-V SIGMAA (A) : 0.24
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES.
REMARK 3 BOND LENGTHS (A) : 0.011
REMARK 3 BOND ANGLES (DEGREES) : 1.800
REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL
REMARK 3 IMPROPER ANGLES (DEGREES) : NULL
REMARK 3
REMARK 3 ISOTROPIC THERMAL MODEL : NULL
REMARK 3
REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA
REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL
REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL
REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL
REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL
REMARK 3
REMARK 3 BULK SOLVENT MODELING.
REMARK 3 METHOD USED : CNS BULK SOLVENT MODEL USED
REMARK 3 KSOL : 0.39
REMARK 3 BSOL : 50.44
REMARK 3
REMARK 3 NCS MODEL : NULL
REMARK 3
REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT
REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL
REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL
REMARK 3
REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM
REMARK 3 PARAMETER FILE 2 : CARBOHYDRATE.PARAM
REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM
REMARK 3 PARAMETER FILE 4 : ION.PARAM
REMARK 3 PARAMETER FILE 5 : FAST1_PPACK.PARAM
REMARK 3 PARAMETER FILE 6 : NULL
REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP
REMARK 3 TOPOLOGY FILE 2 : CARBOHYDRATE.TOP
REMARK 3 TOPOLOGY FILE 3 : ION.TOP
REMARK 3 TOPOLOGY FILE 4 : WATER.TOP
REMARK 3 TOPOLOGY FILE 5 : FAST1_PPACK.TOP
REMARK 3 TOPOLOGY FILE 6 : NULL
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4
REMARK 4 1SHH COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 02-MAR-04.
REMARK 100 THE DEPOSITION ID IS D_1000021710.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 06-APR-03
REMARK 200 TEMPERATURE (KELVIN) : 110
REMARK 200 PH : 6.6
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y
REMARK 200 RADIATION SOURCE : APS
REMARK 200 BEAMLINE : 14-BM-C
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 0.9000
REMARK 200 MONOCHROMATOR : BENT GE 111
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : CCD
REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO
REMARK 200 DATA SCALING SOFTWARE : SCALEPACK
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 94467
REMARK 200 RESOLUTION RANGE HIGH (A) : 1.550
REMARK 200 RESOLUTION RANGE LOW (A) : 81.470
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 94.0
REMARK 200 DATA REDUNDANCY : 5.500
REMARK 200 R MERGE (I) : NULL
REMARK 200 R SYM (I) : 0.05600
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 27.5000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.55
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.61
REMARK 200 COMPLETENESS FOR SHELL (%) : 62.9
REMARK 200 DATA REDUNDANCY IN SHELL : NULL
REMARK 200 R MERGE FOR SHELL (I) : NULL
REMARK 200 R SYM FOR SHELL (I) : 0.35100
REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.400
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: MOLREP IN CCP4, CCP4 (MOLREP)
REMARK 200 STARTING MODEL: NULL
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 50.59
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.49
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: 16-22% PEG MONOMETHYL ETHER 2000, 50
REMARK 280 MM BIS-TRIS, PH 6.6, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE
REMARK 280 293.0K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X+1/2,-Y,Z+1/2
REMARK 290 3555 -X,Y+1/2,-Z+1/2
REMARK 290 4555 X+1/2,-Y+1/2,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 30.67000
REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 81.46500
REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 34.10000
REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 81.46500
REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 30.67000
REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 34.10000
REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1, 2
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 300 REMARK: THERE ARE TWO BIOLOGICAL ASSEMBLIES IN THE ASYMMETRIC UNIT.
REMARK 300 ASSEMBLY 1 CONSISTS OF CHAINS A AND B. ASSEMBLY 2 CONSISTS OF
REMARK 300 CHAINS D AND E.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 TOTAL BURIED SURFACE AREA: 3360 ANGSTROM**2
REMARK 350 SURFACE AREA OF THE COMPLEX: 12510 ANGSTROM**2
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -14.0 KCAL/MOL
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 350
REMARK 350 BIOMOLECULE: 2
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 TOTAL BURIED SURFACE AREA: 3410 ANGSTROM**2
REMARK 350 SURFACE AREA OF THE COMPLEX: 13100 ANGSTROM**2
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -10.0 KCAL/MOL
REMARK 350 APPLY THE FOLLOWING TO CHAINS: D, E
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 THR A 1H
REMARK 465 PHE A 1G
REMARK 465 GLY A 1F
REMARK 465 SER A 1E
REMARK 465 GLY A 1D
REMARK 465 GLY A 14M
REMARK 465 ARG A 14N
REMARK 465 THR B 148A
REMARK 465 ALA B 148B
REMARK 465 ASN B 148C
REMARK 465 VAL B 148D
REMARK 465 GLY B 148E
REMARK 465 GLY B 246
REMARK 465 GLU B 247
REMARK 465 THR D 1H
REMARK 465 PHE D 1G
REMARK 465 GLY D 1F
REMARK 465 SER D 1E
REMARK 465 GLY D 1D
REMARK 465 GLU D 1C
REMARK 465 ARG D 14N
REMARK 465 GLY E 246
REMARK 465 GLU E 247
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: COVALENT BOND ANGLES
REMARK 500
REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES
REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE
REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1)
REMARK 500
REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999
REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996
REMARK 500
REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3
REMARK 500 LEU B 65 CA - CB - CG ANGL. DEV. = 14.3 DEGREES
REMARK 500 CYS E 42 CA - CB - SG ANGL. DEV. = 7.7 DEGREES
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 ALA A 1B -125.23 47.54
REMARK 500 PHE A 7 -84.97 -130.13
REMARK 500 ILE A 14K -70.37 -93.46
REMARK 500 TYR B 60A 84.12 -154.34
REMARK 500 ASN B 60G 78.82 -164.31
REMARK 500 THR B 74 30.12 -93.60
REMARK 500 ILE B 79 -59.76 -120.59
REMARK 500 GLU B 97A -65.28 -121.75
REMARK 500 SER B 214 -57.35 -122.97
REMARK 500 PHE D 7 -84.95 -133.51
REMARK 500 TYR E 60A 83.17 -158.55
REMARK 500 ASN E 60G 76.47 -159.32
REMARK 500 HIS E 71 -59.70 -132.03
REMARK 500 ASN E 78 -49.99 87.89
REMARK 500 GLU E 97A -80.66 -113.52
REMARK 500 TRP E 148 -80.92 -98.67
REMARK 500 ASN E 204B 12.67 -144.22
REMARK 500 SER E 214 -57.29 -122.21
REMARK 500
REMARK 500 REMARK: NULL
REMARK 600
REMARK 600 HETEROGEN
REMARK 600
REMARK 600 THE INHIBITOR IS COVALENTLY CONNECTED TO ACTIVE_SITE
REMARK 600 RESIDUES:
REMARK 600 1) VIA A HEMIKETAL GROUP TO OG SER 195 IN CHAINS B AND E,
REMARK 600 2) VIA A METHYLENE GROUP TO NE2 HIS 57 IN CHAINS B AND E.
REMARK 630
REMARK 630 MOLECULE TYPE: PEPTIDE-LIKE INHIBITOR
REMARK 630 MOLECULE NAME: D-PHENYLALANYL-N-[(2S,3S)-6-{[AMINO(IMINIO)METHYL]
REMARK 630 AMINO}-1-CHLORO-2-HYDROXYHEXAN-3-YL]-L-PROLINAMIDE
REMARK 630 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 630 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 630
REMARK 630 M RES C SSSEQI
REMARK 630 0G6 B 301
REMARK 630 0G6 E 301
REMARK 630 SOURCE: NULL
REMARK 630 TAXONOMY: NULL
REMARK 630 SUBCOMP: DPN PRO AR7 0QE
REMARK 630 DETAILS: NULL
REMARK 900
REMARK 900 RELATED ENTRIES
REMARK 900 RELATED ID: 1SGI RELATED DB: PDB
REMARK 900 RELATED ID: 1SFQ RELATED DB: PDB
REMARK 900 RELATED ID: 1SG8 RELATED DB: PDB
DBREF 1SHH A 1H 14N UNP P00734 THRB_HUMAN 328 363
DBREF 1SHH D 1H 14N UNP P00734 THRB_HUMAN 328 363
DBREF 1SHH B 16 247 UNP P00734 THRB_HUMAN 364 622
DBREF 1SHH E 16 247 UNP P00734 THRB_HUMAN 364 622
SEQADV 1SHH ALA B 77A UNP P00734 ARG 436 ENGINEERED MUTATION
SEQADV 1SHH ALA E 77A UNP P00734 ARG 436 ENGINEERED MUTATION
SEQRES 1 A 36 THR PHE GLY SER GLY GLU ALA ASP CYS GLY LEU ARG PRO
SEQRES 2 A 36 LEU PHE GLU LYS LYS SER LEU GLU ASP LYS THR GLU ARG
SEQRES 3 A 36 GLU LEU LEU GLU SER TYR ILE ASP GLY ARG
SEQRES 1 B 259 ILE VAL GLU GLY SER ASP ALA GLU ILE GLY MET SER PRO
SEQRES 2 B 259 TRP GLN VAL MET LEU PHE ARG LYS SER PRO GLN GLU LEU
SEQRES 3 B 259 LEU CYS GLY ALA SER LEU ILE SER ASP ARG TRP VAL LEU
SEQRES 4 B 259 THR ALA ALA HIS CYS LEU LEU TYR PRO PRO TRP ASP LYS
SEQRES 5 B 259 ASN PHE THR GLU ASN ASP LEU LEU VAL ARG ILE GLY LYS
SEQRES 6 B 259 HIS SER ARG THR ARG TYR GLU ALA ASN ILE GLU LYS ILE
SEQRES 7 B 259 SER MET LEU GLU LYS ILE TYR ILE HIS PRO ARG TYR ASN
SEQRES 8 B 259 TRP ARG GLU ASN LEU ASP ARG ASP ILE ALA LEU MET LYS
SEQRES 9 B 259 LEU LYS LYS PRO VAL ALA PHE SER ASP TYR ILE HIS PRO
SEQRES 10 B 259 VAL CYS LEU PRO ASP ARG GLU THR ALA ALA SER LEU LEU
SEQRES 11 B 259 GLN ALA GLY TYR LYS GLY ARG VAL THR GLY TRP GLY ASN
SEQRES 12 B 259 LEU LYS GLU THR TRP THR ALA ASN VAL GLY LYS GLY GLN
SEQRES 13 B 259 PRO SER VAL LEU GLN VAL VAL ASN LEU PRO ILE VAL GLU
SEQRES 14 B 259 ARG PRO VAL CYS LYS ASP SER THR ARG ILE ARG ILE THR
SEQRES 15 B 259 ASP ASN MET PHE CYS ALA GLY TYR LYS PRO ASP GLU GLY
SEQRES 16 B 259 LYS ARG GLY ASP ALA CYS GLU GLY ASP SER GLY GLY PRO
SEQRES 17 B 259 PHE VAL MET LYS SER PRO PHE ASN ASN ARG TRP TYR GLN
SEQRES 18 B 259 MET GLY ILE VAL SER TRP GLY GLU GLY CYS ASP ARG ASP
SEQRES 19 B 259 GLY LYS TYR GLY PHE TYR THR HIS VAL PHE ARG LEU LYS
SEQRES 20 B 259 LYS TRP ILE GLN LYS VAL ILE ASP GLN PHE GLY GLU
SEQRES 1 D 36 THR PHE GLY SER GLY GLU ALA ASP CYS GLY LEU ARG PRO
SEQRES 2 D 36 LEU PHE GLU LYS LYS SER LEU GLU ASP LYS THR GLU ARG
SEQRES 3 D 36 GLU LEU LEU GLU SER TYR ILE ASP GLY ARG
SEQRES 1 E 259 ILE VAL GLU GLY SER ASP ALA GLU ILE GLY MET SER PRO
SEQRES 2 E 259 TRP GLN VAL MET LEU PHE ARG LYS SER PRO GLN GLU LEU
SEQRES 3 E 259 LEU CYS GLY ALA SER LEU ILE SER ASP ARG TRP VAL LEU
SEQRES 4 E 259 THR ALA ALA HIS CYS LEU LEU TYR PRO PRO TRP ASP LYS
SEQRES 5 E 259 ASN PHE THR GLU ASN ASP LEU LEU VAL ARG ILE GLY LYS
SEQRES 6 E 259 HIS SER ARG THR ARG TYR GLU ALA ASN ILE GLU LYS ILE
SEQRES 7 E 259 SER MET LEU GLU LYS ILE TYR ILE HIS PRO ARG TYR ASN
SEQRES 8 E 259 TRP ARG GLU ASN LEU ASP ARG ASP ILE ALA LEU MET LYS
SEQRES 9 E 259 LEU LYS LYS PRO VAL ALA PHE SER ASP TYR ILE HIS PRO
SEQRES 10 E 259 VAL CYS LEU PRO ASP ARG GLU THR ALA ALA SER LEU LEU
SEQRES 11 E 259 GLN ALA GLY TYR LYS GLY ARG VAL THR GLY TRP GLY ASN
SEQRES 12 E 259 LEU LYS GLU THR TRP THR ALA ASN VAL GLY LYS GLY GLN
SEQRES 13 E 259 PRO SER VAL LEU GLN VAL VAL ASN LEU PRO ILE VAL GLU
SEQRES 14 E 259 ARG PRO VAL CYS LYS ASP SER THR ARG ILE ARG ILE THR
SEQRES 15 E 259 ASP ASN MET PHE CYS ALA GLY TYR LYS PRO ASP GLU GLY
SEQRES 16 E 259 LYS ARG GLY ASP ALA CYS GLU GLY ASP SER GLY GLY PRO
SEQRES 17 E 259 PHE VAL MET LYS SER PRO PHE ASN ASN ARG TRP TYR GLN
SEQRES 18 E 259 MET GLY ILE VAL SER TRP GLY GLU GLY CYS ASP ARG ASP
SEQRES 19 E 259 GLY LYS TYR GLY PHE TYR THR HIS VAL PHE ARG LEU LYS
SEQRES 20 E 259 LYS TRP ILE GLN LYS VAL ILE ASP GLN PHE GLY GLU
MODRES 1SHH ASN E 60G ASN GLYCOSYLATION SITE
HET 0G6 B 301 30
HET 0G6 E 301 30
HET NAG E 701 15
HETNAM 0G6 D-PHENYLALANYL-N-[(2S,3S)-6-{[AMINO(IMINIO)
HETNAM 2 0G6 METHYL]AMINO}-1-CHLORO-2-HYDROXYHEXAN-3-YL]-L-
HETNAM 3 0G6 PROLINAMIDE
HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE
HETSYN 0G6 PPACK
HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA-
HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO-
HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE
FORMUL 5 0G6 2(C21 H34 CL N6 O3 1+)
FORMUL 7 NAG C8 H15 N O6
FORMUL 8 HOH *483(H2 O)
HELIX 1 1 PHE A 7 SER A 11 5 5
HELIX 2 2 THR A 14B TYR A 14J 1 9
HELIX 3 3 ALA B 55 CYS B 58 5 4
HELIX 4 4 PRO B 60B ASP B 60E 5 4
HELIX 5 5 THR B 60I ASN B 62 5 3
HELIX 6 6 ASP B 125 LEU B 130 1 9
HELIX 7 7 GLU B 164 SER B 171 1 8
HELIX 8 8 LEU B 234 PHE B 245 1 12
HELIX 9 9 PHE D 7 SER D 11 5 5
HELIX 10 10 THR D 14B ASP D 14L 1 11
HELIX 11 11 ALA E 55 CYS E 58 5 4
HELIX 12 12 PRO E 60B ASP E 60E 5 4
HELIX 13 13 THR E 60I ASN E 62 5 3
HELIX 14 14 ASP E 125 LEU E 130 1 9
HELIX 15 15 GLU E 164 SER E 171 1 8
HELIX 16 16 LYS E 185 GLY E 186C 5 5
HELIX 17 17 LEU E 234 PHE E 245 1 12
SHEET 1 A 7 SER B 20 ASP B 21 0
SHEET 2 A 7 GLN B 156 PRO B 161 -1 O VAL B 157 N SER B 20
SHEET 3 A 7 LYS B 135 GLY B 140 -1 N GLY B 136 O LEU B 160
SHEET 4 A 7 PRO B 198 LYS B 202 -1 O VAL B 200 N ARG B 137
SHEET 5 A 7 TRP B 207 TRP B 215 -1 O TYR B 208 N MET B 201
SHEET 6 A 7 GLY B 226 HIS B 230 -1 O PHE B 227 N TRP B 215
SHEET 7 A 7 MET B 180 ALA B 183 -1 N PHE B 181 O TYR B 228
SHEET 1 B 7 GLN B 30 ARG B 35 0
SHEET 2 B 7 GLU B 39 LEU B 46 -1 O LEU B 41 N LEU B 33
SHEET 3 B 7 TRP B 51 THR B 54 -1 O LEU B 53 N SER B 45
SHEET 4 B 7 ALA B 104 LEU B 108 -1 O ALA B 104 N THR B 54
SHEET 5 B 7 LYS B 81 ILE B 90 -1 N GLU B 86 O LYS B 107
SHEET 6 B 7 LEU B 64 ILE B 68 -1 N ILE B 68 O LYS B 81
SHEET 7 B 7 GLN B 30 ARG B 35 -1 N PHE B 34 O LEU B 65
SHEET 1 C 2 LEU B 60 TYR B 60A 0
SHEET 2 C 2 LYS B 60F ASN B 60G-1 O LYS B 60F N TYR B 60A
SHEET 1 D 7 SER E 20 ASP E 21 0
SHEET 2 D 7 GLN E 156 PRO E 161 -1 O VAL E 157 N SER E 20
SHEET 3 D 7 LYS E 135 GLY E 140 -1 N VAL E 138 O VAL E 158
SHEET 4 D 7 PRO E 198 LYS E 202 -1 O VAL E 200 N ARG E 137
SHEET 5 D 7 TRP E 207 TRP E 215 -1 O TYR E 208 N MET E 201
SHEET 6 D 7 GLY E 226 HIS E 230 -1 O PHE E 227 N TRP E 215
SHEET 7 D 7 MET E 180 ALA E 183 -1 N PHE E 181 O TYR E 228
SHEET 1 E 7 GLN E 30 ARG E 35 0
SHEET 2 E 7 GLU E 39 LEU E 46 -1 O GLU E 39 N ARG E 35
SHEET 3 E 7 TRP E 51 THR E 54 -1 O LEU E 53 N SER E 45
SHEET 4 E 7 ALA E 104 LEU E 108 -1 O MET E 106 N VAL E 52
SHEET 5 E 7 LYS E 81 ILE E 90 -1 N GLU E 86 O LYS E 107
SHEET 6 E 7 LEU E 64 ILE E 68 -1 N ILE E 68 O LYS E 81
SHEET 7 E 7 GLN E 30 ARG E 35 -1 N PHE E 34 O LEU E 65
SHEET 1 F 2 LEU E 60 TYR E 60A 0
SHEET 2 F 2 LYS E 60F ASN E 60G-1 O LYS E 60F N TYR E 60A
SSBOND 1 CYS A 1 CYS B 122 1555 1555 2.04
SSBOND 2 CYS B 42 CYS B 58 1555 1555 2.05
SSBOND 3 CYS B 168 CYS B 182 1555 1555 2.04
SSBOND 4 CYS B 191 CYS B 220 1555 1555 2.03
SSBOND 5 CYS D 1 CYS E 122 1555 1555 2.05
SSBOND 6 CYS E 42 CYS E 58 1555 1555 2.05
SSBOND 7 CYS E 168 CYS E 182 1555 1555 2.04
SSBOND 8 CYS E 191 CYS E 220 1555 1555 2.04
LINK NE2 HIS B 57 C3 0G6 B 301 1555 1555 1.48
LINK OG SER B 195 C2 0G6 B 301 1555 1555 1.36
LINK NE2 HIS E 57 C3 0G6 E 301 1555 1555 1.47
LINK ND2 ASN E 60G C1 NAG E 701 1555 1555 1.46
LINK OG SER E 195 C2 0G6 E 301 1555 1555 1.34
CISPEP 1 SER B 36A PRO B 37 0 -0.56
CISPEP 2 SER E 36A PRO E 37 0 -0.55
CRYST1 61.340 68.200 162.930 90.00 90.00 90.00 P 21 21 21 8
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.016303 0.000000 0.000000 0.00000
SCALE2 0.000000 0.014663 0.000000 0.00000
SCALE3 0.000000 0.000000 0.006138 0.00000